13C-mixed triglyceride breath test for evaluation of pancreatic exocrine function in diabetes mellitus

Pancreas

Volumn 43, Issue 6, 2014, Pages 842-848

  Keller, Jutta ^a   Layer, Peter ^a   Brückel, Sebastian ^a   Jahr, Christine ^a   Rosien, Ulrich ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

13C breath test; chronic pancreatitis; diabetes mellitus; enzymes; lipid digestion; pancreatic function test

Indexed keywords

AMYLASE; CARBON 13; CERULETIDE; SECRETIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL CARBON 13; TRIACYLGLYCEROL LIPASE; TRYPSIN; UNCLASSIFIED DRUG; CARBON;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; PANCREAS FUNCTION; PANCREAS FUNCTION TEST; PANCREAS SECRETION; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH EMPTYING; YOUNG ADULT; DIAGNOSTIC USE; EXOCRINE PANCREATIC INSUFFICIENCY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PATHOPHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BREATH TESTS; CARBON ISOTOPES; CERULETIDE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREAS, EXOCRINE; PANCREATIC FUNCTION TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SECRETIN; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES; YOUNG ADULT;

EID: 84904383464     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000121     Document Type: Article

References (30)

1. Löhr M, Klöppel G. Pathology of the pancreas in chronic type 1 diabetes mellitus: B-cell content, exocrine atrophy and angiopathy. Verh Dtsch Ges Pathol. 1987;71:114-119.
2. Philippe MF, Benabadji S, Barbot-Trystram L, et al. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas. 2011;40:359-363.
3. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005;54(suppl 6):vi1-vi28. (Pubitemid 40868314)
4. Lieb JG 2nd, Draganov PV. Pancreatic function testing: here to stay for the 21st century. World J Gastroenterol. 2008;14:3149-3158.
5. Stevens T, Conwell DL, Zuccaro G Jr, et al. The efficiency of endoscopic pancreatic function testing is optimized using duodenal aspirates at 30 and 45 minutes after intravenous secretin. Am J Gastroenterol. 2007;102:297-301. (Pubitemid 46160543)
6. Hardt PD, Hauenschild A, Nalop J, et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1, 021 diabetic patients. Pancreatology. 2003;3:395-402. (Pubitemid 37409868)
7. Hardt PD, Krauss A, Bretz L, et al. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol. 2000;37:105-110. (Pubitemid 32157309)
8. Icks A, Haastert B, Giani G, et al. Low fecal elastase-1 in type I diabetes mellitus. Z Gastroenterol. 2001;39:823-830. (Pubitemid 33020961)
9. Siegmund E, Löhr JM, Schuff-Werner P. The diagnostic validity of non-invasive pancreatic function testsVa meta-analysis. Z Gastroenterol. 2004;42:1117-1128. (Pubitemid 39486910)
10. Brydon WG, Kingstone K, Ghosh S. Limitations of faecal elastase-1 and chymotrypsin as tests of exocrine pancreatic disease in adults. Ann Clin Biochem. 2004;41:78-81. (Pubitemid 38175101)
11. Lankisch PG. Now that fecal elastase is available in the United States, should clinicians start using it? Curr Gastroenterol Rep. 2004;6:126-131. (Pubitemid 38915059)
12. Hahn JU, Kerner W, Maisonneuve P, et al. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas. 2008;36:274-278. (Pubitemid 351440932)
13. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973;288:813-815.
14. Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001;96:71-76. (Pubitemid 32104810)
15. Vantrappen GR, Rutgeerts PJ, Ghoos YF, et al. Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology. 1989;96:1126-1134. (Pubitemid 19091129)
16. 13C-mixed triglyceride breath test detects moderate pancreatic exocrine insufficiency. Pancreas. 2011;40:1201-1205.
17. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995;82:216-222.
18. Rauscher E, Neumann U, Schaich E, et al. Optimized conditions for determining activity concentration of alpha-amylase in serum, with 1, 4-alpha-D-4-nitrophenylmaltoheptaoside as substrate. Clin Chem. 1985;31:14-19. (Pubitemid 15079337)
19. Neumann U, Ziegenhorn J. Determination of serum lipase with automated systems. Biologie Prospective. Paris, France. Comptes-rendus du 4e Colloque de Pont-á-Mousson; 1979:627-634.
20. Kruse-Jarres JD, Kaiser C, Hafkenscheid JC, et al. Evaluation of a new alpha-amylase assay using 4.6-ethylidene-(G7)-1-4-nitrophenyl-(G1)-alpha-D- maltoheptaoside as substrate. J Clin Chem Clin Biochem. 1989;27:103-113. (Pubitemid 19065828)
21. Hummel BC. A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin. Can J Biochem Physiol. 1959;37:1393-1397.
22. Ghoos YF, Maes BD, Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology. 1993;104:1640-1647. (Pubitemid 23235453)
23. 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil. 2009;21:1039-1046.
24. 13C-octanoic acid breath test for gastric emptying measurement. Eur J Gastroenterol Hepatol. 2000;12:85-91. (Pubitemid 30072110)
25. 13C mixed-triglyceride breath test: isotope selective non-dispersive infrared spectrometry in comparison with isotope ratio mass spectrometry in volunteers and patients with chronic pancreatitis. Scand J Gastroenterol. 1999;34:1153-1156. (Pubitemid 29533776)
26. 2 response. Eur J Clin Invest. 1997;27:434-442. (Pubitemid 27242516)
27. Granderath FA, Kamolz T, Schweiger UM, et al. Long-term follow-up after laparoscopic refundoplication for failed antireflux surgery: quality of life, symptomatic outcome, and patient satisfaction. J Gastrointest Surg. 2002;6:812-818. (Pubitemid 40433467)
28. Lam WF, Gielkens HA, Coenraad M, et al. Effect of insulin and glucose on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans. Pancreas. 1999;18:252-258. (Pubitemid 29149204)
29. Reddymasu SC, McCallum RW. Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? J Clin Gastroenterol. 2010;44:e8-e13.
30. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16:2978-2990.